Open-label Study of Loncastuximab Tesirine for Treating Relapsed or Difficult-to-Treat Marginal Zone Lymphoma | Clinical Trial

Open-label Study of Loncastuximab Tesirine for Treating Relapsed or Difficult-to-Treat Marginal Zone Lymphoma | Clinical Trial | Right2Hope